首页> 美国卫生研究院文献>Acta Histochemica et Cytochemica >Histological and Immunohistochemical Basis of the Effect of Aminoguanidine on Renal Changes Associated with Hemorrhagic Shock in a Rat Model
【2h】

Histological and Immunohistochemical Basis of the Effect of Aminoguanidine on Renal Changes Associated with Hemorrhagic Shock in a Rat Model

机译:氨基胍对大鼠模型失血性休克相关肾脏变化的组织学和免疫组织化学基础

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Acute kidney failure is the main cause of death among patients with severe trauma due to massive blood loss and hemorrhagic shock (HS). Renal cell injury is caused by tissue ischemia. Renal ischemia initiates a complex and interconnected chain of events resulting in cell injury and renal cell necrosis. Nitric oxide plays a crucial role in renal function and can be inhibited by aminoguanidine (AG). We studied whether AG can ameliorate pathological renal changes associated with HS syndrome in a rat model and explored the AG protection mechanism. Rats were intraperitoneally injected with heparin sodium and mean arterial blood pressure was monitored. Animals were divided into three groups: control (without hemorrhage), with or without intra-arterially injected AG; HS (blood continuously withdrawn or reinfused to maintain an MABP of 35–40 mmHg); and HS with AG. We found that AG decreased plasma concentrations of urea, creatinine, and nitrates; ameliorated histological changes of HS-induced rats; and decreased the expressions of inducible nitrogen oxide synthase (iNOS), proapoptotic protein (BAX), and vitamin D receptors (VDR). AG ameliorated kidney injury by inhibiting iNOS resulting in decreased BAX and VDR expressions. Therefore, a therapeutic strategy targeting AG may provide new insights into kidney injury during severe shock.
机译:急性肾衰竭是由于大量失血和失血性休克(HS)造成严重创伤的患者的主要死亡原因。肾细胞损伤是由组织缺血引起的。肾缺血引发一系列复杂且相互联系的事件,从而导致细胞损伤和肾细胞坏死。一氧化氮在肾功能中起关键作用,并可以被氨基胍(AG)抑制。我们研究了AG是否可以改善大鼠模型中与HS综合征相关的病理性肾脏变化,并探讨了AG保护机制。给大鼠腹膜内注射肝素钠并监测平均动脉血压。将动物分为三组:对照组(无出血),有或没有动脉内注射AG;对照组(无出血)。 HS(连续抽出或重新注入血液以维持35-40 mmHg的MABP);和HS与AG。我们发现AG降低了尿素,肌酐和硝酸盐的血浆浓度。改善HS诱导的大鼠的组织学变化;并降低了诱导型一氧化氮合酶(iNOS),促凋亡蛋白(BAX)和维生素D受体(VDR)的表达。 AG通过抑制iNOS减轻了BAX和VDR表达,从而减轻了肾脏损害。因此,针对AG的治疗策略可能为重度休克期间的肾脏损伤提供新的见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号